Skip to main content
. 2023 Jan 4;37(1):71–91. doi: 10.1007/s40290-022-00452-w

Fig. 6.

Fig. 6

Median evaluation times reported in the two risk-based assessment pilot studies for low-risk, high-risk, bioequivalence (BE), biowaiver and responses. (n) = number of product applications. Box: 25th and 75th percentiles. Whiskers: 5th and 95th percentiles